ResearcherThe Affiliated Taizhou People's Hospital of Nanjing Medical UniversityActive in the last 2 years

Qiangqiang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-6300-1713; OpenAlex author ID A5101743683. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

Bergamottin demonstrates preclinical effectiveness against pancreatic cancer by modulating PPAR-γ to induce apoptosis. Last author DOI 10.21037/tcr-2026-0837 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Linxiao Sun · 1 shared paper, 2026 · strength 0.43
- Paper Bergamottin demonstrates preclinical effectiveness against pancreatic cancer by modulating PPAR-γ to induce apoptosis. DOI 10.21037/tcr-2026-0837 ↗
Cheng Wang · 1 shared paper, 2026 · strength 0.43
- Paper Bergamottin demonstrates preclinical effectiveness against pancreatic cancer by modulating PPAR-γ to induce apoptosis. DOI 10.21037/tcr-2026-0837 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.